Elite Labs Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ELITE LABS INC
ELITE LABS INC has nineteen approved drugs.
Summary for Elite Labs Inc
| US Patents: | 0 |
| Tradenames: | 14 |
| Ingredients: | 14 |
| NDAs: | 19 |
Drugs and US Patents for Elite Labs Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Elite Labs Inc | TRIMIPRAMINE MALEATE | trimipramine maleate | CAPSULE;ORAL | 077361-002 | Aug 2, 2006 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Elite Labs Inc | ROPINIROLE HYDROCHLORIDE | ropinirole hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 217862-004 | Nov 10, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Elite Labs Inc | METHADONE HYDROCHLORIDE | methadone hydrochloride | TABLET;ORAL | 210484-001 | Aug 2, 2018 | AA | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Elite Labs Inc | LISDEXAMFETAMINE DIMESYLATE | lisdexamfetamine dimesylate | CAPSULE;ORAL | 218604-002 | Nov 15, 2024 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Elite Labs Inc | ROPINIROLE HYDROCHLORIDE | ropinirole hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 217862-005 | Nov 10, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
